EAM
DRNA
Eagle Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-709,674
| Closed | -$14.3M | – | 636 |
|
|
2021
Q3 | $14.3M | Sell |
709,674
-608,373
| -46% | -$12.3M | 0.06% | 253 |
|
|
2021
Q2 | $49.2M | Sell |
1,318,047
-28,379
| -2% | -$1.06M | 0.21% | 157 |
|
|
2021
Q1 | $34.7M | Sell |
1,346,426
-184,226
| -12% | -$4.75M | 0.15% | 194 |
|
|
2020
Q4 | $33.7M | Sell |
1,530,652
-102,948
| -6% | -$2.27M | 0.19% | 175 |
|
|
2020
Q3 | $30M | Buy |
1,633,600
+25,670
| +2% | +$472K | 0.15% | 190 |
|
|
2020
Q2 | $39.7M | Sell |
1,607,930
-134,430
| -8% | -$3.32M | 0.23% | 154 |
|
|
2020
Q1 | $32M | Sell |
1,742,360
-13,452
| -0.8% | -$247K | 0.2% | 172 |
|
|
2019
Q4 | $38.7M | Sell |
1,755,812
-9,344
| -0.5% | -$206K | 0.19% | 192 |
|
|
2019
Q3 | $25.3M | Buy |
+1,765,156
| New | +$25.3M | 0.13% | 211 |
|